Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma.
Barker, Christopher A
Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma. [electronic resource] - International journal of radiation oncology, biology, physics 05 2017 - 11-12 p. digital
Publication Type: Case Reports; Journal Article
1879-355X
10.1016/j.ijrobp.2017.02.213 doi
Aged
Antineoplastic Agents--administration & dosage
Antineoplastic Agents, Immunological--therapeutic use
Humans
Interferons--administration & dosage
Ipilimumab--therapeutic use
Lymph Node Excision--methods
Lymph Nodes--pathology
Lymphatic Irradiation
Male
Melanoma--pathology
Radiotherapy Dosage
Radiotherapy, Adjuvant
Skin Neoplasms--pathology
Melanoma, Cutaneous Malignant
Adjuvant Therapy in High-Risk Stage III Cutaneous Melanoma. [electronic resource] - International journal of radiation oncology, biology, physics 05 2017 - 11-12 p. digital
Publication Type: Case Reports; Journal Article
1879-355X
10.1016/j.ijrobp.2017.02.213 doi
Aged
Antineoplastic Agents--administration & dosage
Antineoplastic Agents, Immunological--therapeutic use
Humans
Interferons--administration & dosage
Ipilimumab--therapeutic use
Lymph Node Excision--methods
Lymph Nodes--pathology
Lymphatic Irradiation
Male
Melanoma--pathology
Radiotherapy Dosage
Radiotherapy, Adjuvant
Skin Neoplasms--pathology
Melanoma, Cutaneous Malignant